TREATMENT OF WOLFRAM SYNDROME-RELATED NEURODEGENERATION

Zsuzsanna Nagy; Timothy Barrett

TREATMENT OF WOLFRAM SYNDROME-RELATED NEURODEGENERATION

Zsuzsanna Nagy (Inventor)
, Timothy Barrett (Inventor)

Research output: Patent

72 Downloads (Pure)

Abstract

Provided is a method of treating and/or preventing Wolfram Syndrome (WS)-related neurodegeneration (i.e. of Wolfram Syndrome-Associated Neuronal Degeneration), by increasing the expression and/or functional activity of p21. A method of screening for pharmacological agents useful in treating and/or preventing such conditions is also provided.

Original language	English
Patent number	WO2014/049366
Publication status	Published - 3 Mar 2014

Access to Document

US2015246037A1

Cite this

@misc{fb7e2a7ac54f4a03bddc469a8cae5694,

title = "TREATMENT OF WOLFRAM SYNDROME-RELATED NEURODEGENERATION",

abstract = "Provided is a method of treating and/or preventing Wolfram Syndrome (WS)-related neurodegeneration (i.e. of Wolfram Syndrome-Associated Neuronal Degeneration), by increasing the expression and/or functional activity of p21. A method of screening for pharmacological agents useful in treating and/or preventing such conditions is also provided.",

author = "Zsuzsanna Nagy and Timothy Barrett",

year = "2014",

month = mar,

day = "3",

language = "English",

type = "Patent",

note = "WO2014/049366",

}

TY - PAT

T1 - TREATMENT OF WOLFRAM SYNDROME-RELATED NEURODEGENERATION

AU - Nagy, Zsuzsanna

AU - Barrett, Timothy

PY - 2014/3/3

Y1 - 2014/3/3

N2 - Provided is a method of treating and/or preventing Wolfram Syndrome (WS)-related neurodegeneration (i.e. of Wolfram Syndrome-Associated Neuronal Degeneration), by increasing the expression and/or functional activity of p21. A method of screening for pharmacological agents useful in treating and/or preventing such conditions is also provided.

AB - Provided is a method of treating and/or preventing Wolfram Syndrome (WS)-related neurodegeneration (i.e. of Wolfram Syndrome-Associated Neuronal Degeneration), by increasing the expression and/or functional activity of p21. A method of screening for pharmacological agents useful in treating and/or preventing such conditions is also provided.

M3 - Patent

M1 - WO2014/049366

ER -

TREATMENT OF WOLFRAM SYNDROME-RELATED NEURODEGENERATION

Abstract

Access to Document

Fingerprint

Cite this